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ABSTRACT
Objective: The purpose of this study was to evaluate the Equate Strep B(R) test for clinical use in
patients at high risk for complications from group B streptococcus (GBS) disease.
Methods: Vaginoperineal swabs were obtained from patients with preterm premature rupture of
the membranes and/or preterm labor and semiquantitative GBS cultures and Equate(R) assay were
performed.
Results: From May 14, 1990, to April 30, 1992, 650 patients were enrolled; 626 had both culture
and Equate(R) results available, ofwhom 24% were colonized with GBS. The sensitivity, specificity,
positive predictive value, and negative predictive value of the rapid assay were 28%, 84%, 35%, and
79%, respectively. Although the prevalence of GBS was higher in patients with ruptured mem-
branes compared with those with intact membranes, rupture of membranes did not affect test
sensitivity or specificity.
Conclusions:We conclude that the Equate(R) rapid assay is not a sensitive method ofGBS detection
in high-risk patients. (C) 1994 Wiley-Liss, Ine.
KEy WORS
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aginal colonization with group B streptococcus
(GBS) occurs in 10-30% of normal pregnan-
cies. Although maternal disease due to GBS coloni-
zation is relatively rare, neonatal colonization oc-
curs in 40-70% of infants born to colonized
women. Approximately 1-2% of colonized infants
ultimately develop early onset neonatal GBS sepsis,
a disease with a high mortality rate and much mor-
bidity. Factors that increase the risk for develop-
ment of GBS sepsis include low birth weight and
prematurity, prolonged membrane rupture, and
maternal factors such as fever in labor and heavy
vaginal colonization.
It has been shown that intrapartum administra-
tion of ampicillin to mothers colonized with GBS
in the 3 rd trimester results in a decrease in neonatal
colonization and neonatal GBS sepsis.
,2 The prob-
lem remains, however, in identifying those patients
who would most benefit from ampicillin prophy-
laxis. Antepartum cultures ave not predictive of
intrapartum colonization status, as only 55-67% of
patients with positive cultures in the 3rd trimester
will have positive cultures at the time of labor, even
in the absence of antibiotic treatment. 3’4 More-
over, approximately 5-10% of patients with nega-
tive antepartum cultures will be colonized when
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TABLE I. Sensitivity, specificity, and predictive value of Equate
(R) rapid GBS detection kit in comparison with
selective GBS culture
All patients Intact membranes Ruptured membranes Heavily colonized
(N 626) (N 394) (N 232) (N 626)
Sensitivity 28% 28% 27% 33%
Specificity 84% 82% 88% 83%
PPV 35% 27% 51% 21%
NPV 79% 83% 72% 91%
Prevalence 24% 19% 32% 12%
evaluated intrapartum. 3’4 Clearly, there is a need
for the ability to rapidly and accurately detect the
presence ofGBS, especially in those patients at high
risk for neonatal GBS sepsis.
Our purpose was to evaluate one of the currently
available rapid test kits for clinical use in a popula-
tion at high risk for maternal GBS colonization and
the subsequent development of neonatal GBS colo-
nization and sepsis.
SUBJECTS AND METHODS
As part of an ongoing study of the use of a rapid
GBS test in the management of high-risk pregnan-
cies, all women admitted to the Medical College of
Virginia Hospital with the diagnosis of preterm
(<37 complete weeks gestation) labor and/or pre-
term premature rupture of the membranes
(PTROM) were offered enrollment in the study.
In addition, those patients who were undergoing a
preterm induction of labor for maternal indications
(usually severe preeclampsia) were eligible. Exclu-
sion criteria included age < 18 years, antibiotic use
in the previous 2 weeks, or a previous infant with
GBS sepsis. The study was approved by the Com-
mittee on the Conduct of Human Research at Vir-
ginia Commonwealth University, and an informed
consent was obtained from all patients.
Three vaginoperineal swabs were obtained from
all study patients at the time of admission to labor
and delivery. Two swabs were transported in cul-
ture media to the clinical microbiology laboratory,
where was streaked onto non-selective medium
(5% sheep blood agar) and the other was placed in
selective enrichment broth (Todd-I--Iewitt broth
supplemented with 5% sheep blood, 0.01 mg/ml of
colistin, and 0.005 mg/ml of oxolinic acid). Fol-
lowing 24 h ofincubation, the broth was plated, again
on non-selective medium. Colonies ofGBS were con-
firmed using Phadebact(R) Strep B latex agglutination
test (Remel, Lenexa, KS), in accordance with the
manufacturer’s recommended procedures.
The 3rd swab, provided in the Equate(R) kit, was
used to perform the Equate(R) assay, as per the
manufacturer’s directions. Following an initial 11-
month trial period during which 37 assays were
performed by 3rd-year house officers, all Equate(R)
assays were performed by of 4 designated labora-
tory technicians.
Results of the culture for GBS were reported
semiquantitatively as containing many, moderate,
or rare colonies or as negative based on the number
of quadrants on the plate that contained growth.
Those samples that resulted in growth only follow-
ing broth incubation were classified as containing
only rare colonies. Equate(R) assays were reported as
positive or negative.
Chi-square analysis was used to compare discrete
variables. P < 0.05 was considered significant.
RESULTS
Between May 14, 1990, and April 30, 1992, 650
patients were enrolled in the study. Of these, 626
had both Equate(R) and vaginal culture results avail-
able. The mean age of the study participants was
24.6 5.7 years and the mean gestational age at
enrollment was 32.2 + 3.3 weeks. Thirty-five per-
cent of the patients were nulliparous, while 21%
had a history of preterm birth. Three hundred
twenty-eight (52%) of the patients were admitted
with preterm labor, 231 (37%) with PTROM,
and 67 (11%) were enrolled at the time of preterm
induction. All patients in the latter group had intact
membranes at enrollment.
One hundred forty-nine (24%) of the patients
were culture positive for GBS. Of these, 77 (52%)
had rare, 54 (36%) had moderate, and 18 (12%)
had many colonies. Table illustrates the results of
the Equate(R) assay compared with culture.
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TABLE 2. Summary of performance in clinical settings of different antigen detection tests for GBS in
comparison with culture
GBS
Reference Assay type Patient population Prevalence Sensitivity Specificity PPV NP
Towers et al.s EIA
(Equate
(R)
Skoll et al. EIA
(Equate
(R)
Greenspoon et al. EIA
(Equate
(R)
Gentry et al. EIA
(ICON
(R)
Armer et al. EIA
(ICON
(R)
Isada and Grossman 12 LA
(Bactigen(R))
Brady et a1.14 LA
(Directigen (R))
Clark et al.I LA
(Directigen (R))
Green et al.3 LA
Greenspoon et al.
Skoll et al.
Kontnick and Edberg
(Directigen (R))
(Bactigen(R))
LA
(Bactigen (R))
LA
(Streptex(R))
(Streptex(R))
Antepartum
N= 31
Laboring
N ,052
Laboring
N 250
Laboring
N 300
Laboring
N= 82
Laboring
N =431
Laboring
N 500
Laboring
N 314
Laboring
N 4,251
Laboring
N 250
Laboring
N 1,060
Antepartum
N 434
12% 60% 92% 57% 93%
9% 15% 99% 67% 92%
2% 33% 99% 40% 98%
10% 33% 9S% 24% 93%
2:% I% 100% 100% 78%
4% 58% 93% 28% 98%
5% 88% 100% 92% 99%
29% 30% 93% 63% 76%
5%
2%
9%
15%
24% 99% 81% 96%
20% 99% 79% 96%
33% 95% 5% 98%
15% 99% 67% 92%
19% 100% 92% 88%
EIA enzyme immunoassay.
bLA latex agglutination.
cCompared with GBS culture on selective medium.
When patients with intact membranes were ana-
lyzed separately from those with PTROM, the
results were similar. Although the sensitivity and
specificity were essentially the same, the positive
predictive value (PPV) was higher and the negative
predictive value (NPV) was lower in those patients
with PTROM. This finding is not surprising,
given the significantly higher prevalence of GBS
colonization in the patients with PTROM (32%
vs. 19%, P 0.004).
Because prior studies of rapid GBS detection
systems have shown improved sensitivity when ap-
plied only to those patients with heavy vaginal col-
onization,
5- we then analyzed our results consid-
ering only those patients with heavy colonization,
defining moderate or many colonies (>2 quadrants
on the initial plate or > 100,000 cfu/ml) as positive
(N 72). As shown in Table 1, the sensitivity and
NPV of the rapid test also improved in our study,
although marginally, when only heavy maternal
colonization was considered. The false negative rate,
or the percentage of carriers not identified, increases
with decreasing colony counts. Thirteen percent of
those with rare colonies, 8% of those with moderate
colonies, and 3% ofwomen with many colonies were
not detected by the rapid test.
DISCUSSION
Although the first studies to utilize rapid detection
tests reported high sensitivities for the detection of
GBS (58% by Isada and Grossman
12 and 88% by
Brady et a1.14), these results have been criticized
for comparing the rapid tests with culture results
obtained with non-selective medium. Subsequent
studies of these particular rapid tests as well as
others have reported much lower sensitivities (Ta-
ble 2).
Our finding that the sensitivity of the Equate(R)
vapid enzyme immunoassay is low is in agreement
with other investigators, including those who have
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used non-selective culture medium to detect GBS
colonization. Although using selective medium for
comparison could result in lower sensitivities, we
optimized sensitivity by limiting the number of
personnel who performed the test, using the swab
supplied with the Equate(R) kit, using reagents at
room temperature, and performing the test imme-
diately, following the manufacturer’s directions ex-
actly. Although one group
5 reported a sensitivity
of 60% and specificity of 92% for the Equate(R)
assay in antepartum patients, other studies in labor-
ing patients have reported much lower sensitivities
of 22% and 33%. s’6 It is possible that there are
substances present in the vagina of laboring women
that might interfere with the rapid test and partially
explain the lower sensitivities seen in these patients.
Results with other rapid test methods have
proven equally disappointing. Using a different
immunoenzyme assay (ICON Strep B(R)), Gentry
et al.
7 reported a sensitivity of 33%, and Armer et
al. reported a sensitivity of 11%. Both authors
conclude that the assay is not sufficiently sensitive
in detecting light colonization, precluding routine
use in the clinical setting. Additional studies using
latex agglutination tests have resulted in similar
findings, with sensitivities ranging from 15 to 30%
and specificities from 93 to 100%, with NPVs of
76-88% in those populations with significant colo-
nization rates. 5’6’-14
Using yet another enzyme immunoassay
(Quidel(R)), Granato and Petosa
9 reported a sensi-
tivity of 89%, a specificity of 99%, and an NPV of
99% in comparison with culture on non-selective
medium. However, when lightly colonized women
are included, the sensitivity decreases to 74%. It
remains to be seen whether this rapid test will be
adequately sensitive when compared with culture
using selective medium.
Although many investigators have found in-
creased sensitivity when the rapid tests were applied
only to heavily colonized women, whether detec-
tion of only heavily colonized mothers is adequate
is a matter of some discussion.
8, 0,6 Isada and
Grossman
2 found that, in a population with a GBS
prevalence of4.4%, all 9 cases of "clinically signif-
icant" perinatal GBS morbidity were identified us-
ing a rapid latex agglutination test, including 5
cases of neonatal GBS sepsis. Although heavy ma-
ternal colonization increases the risk for neonatal
GBS sepsis, many cases of neonatal GBS sepsis have
been reported following delivery of women who
were only lightly colonized.2’8’5-7
A prospective study by Tuppurainen and Hall-
man
8 found that using a latex agglutination test
(Streptolatex, Orion Diagnostica, Finland) for se-
lecting those intrapartum patients to be randomized
to receive prophylactic penicillin or placebo re-
sulted in neonatal GBS disease in 0.07% of the
rapid-test negative (untreated) group. Nine percent
of the neonates born to rapid-test positive patients
who received placebo developed GBS disease, while
1.1% of the neonates born to treated women had
GBS disease. In a similar study, Morales and Lim
7
performed rapid tests on 260 patients with
PTROM. Eighty-four patients had positive rapid
tests, 36 ofwhom were given antibiotic prophylaxis
prior to delivery. Although patients with positive
rapid tests who were untreated were more likely to
develop chorioamnionitis (13% vs. 0) and to de-
liver neonates who developed neonatal sepsis (15%
vs. 0), no results are reported for those women who
were rapid-test negative. As a result, it is impossi-
ble to evaluate the effectiveness of this treatment
protocol.
Unless chemoprophylaxis protocols based on the
use of rapid assays for the intrapartum detection of
maternal GBS colonization can be shown to result
in similar or lower neonatal GBS colonization and
sepsis rates compared with current perhaps less se-
lective management protocols,
9 the use of the
Equate(R) assay in the intrapartum management of
high-risk pregnancies is to be discouraged.
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